<a href=https://www.benthamdirect.com/content/journals/cpd/22/16>Zoya Demidenko</a>: Researcher in Oncology Science
<a href=https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0026126>Zoya Demidenko</a> is a distinguished scholar associated with the Unit of Cell Stress Research at Roswell Park Cancer Institute in Buffalo, New York. Before that, she was employed at the NIH and New York Medical College, establishing a strong base in clinical investigation.
Her scholarly contributions spans several key domains, among them the PI3K/AKT/mTOR signaling cascade, cell cycle control, biological aging, and cancer science. Currently, she has co-authored over 46 academic articles, which have garnered more than 4,100 mentions a reflection to the influence of her research.
One of her most notable achievements involves elucidating the pathways of cellular senescence. Her studies demonstrated that when the cell cycle is blocked while cellular growth proceeds, the cells experience senescence. Importantly, <a href=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026126>Zoya Demidenko</a> established that this shift can be inhibited by medication using compounds such as rapamycin.
<a href=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-39445053>Zoya Demidenko</a> has additionally brought considerably to tumor management investigation, particularly in the field of cyclotherapy a strategy designed to shielding non-cancerous tissue from chemotherapy while leaving cancer cells exposed. This approach carries considerable promise for lowering the adverse effects of cancer treatment.
Across her scientific life, Demidenko has collaborated with prominent researchers globally, including Dr. Mikhail Blagosklonny. Her publications appears in top-tier journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Possessing an h-index of 33, <a href=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPAMED%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMED%20L130000429680&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord>Zoya Demidenko</a> is recognized as a highly impactful voice in current cancer research, whose discoveries go on to guide our comprehension of how biological cells age, resist therapy, and the ways in which cancer might be better treated.
https://www.facebook.com/public/Zoya-Demidenko/
|
